Studies have shown that CTLA-4 gene polymorphism is associated with genetic susceptibility to LADA, and the distribution of CTLA-4 +49A/G genotype in LADA patients is associated with GADA titers (49, 50). This evidence concerns the gene CTLA4 and latent autoimmune diabetes in adults.